Recent News

• 04.21.2025 - World Vaccine Congress: The potential of Novavax’s technology platform and Matrix-M® adjuvant

Recent Filings

• 04.14.2025 - 144 Report of proposed sale of securities
• 04.02.2025 - 8-K Current report
• 03.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.12.2025 - 3 Initial statement of beneficial ownership of securities
• 03.11.2025 - 8-K Current report
• 03.11.2025 - EX-99.1 EX-99.1
• 03.11.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.11.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.11.2025 - 8-K Current report
• 03.05.2025 - 4 Statement of changes in beneficial ownership of securities